Epirus Biopharmaceuticals

About:

Epirus Biopharmaceuticals develops biosimilar monoclonal antibodies and therapeutic proteins for emerging markets.

Website: https://epirusbiopharma.com/

Top Investors: Mousse Partners, Adage Capital Management, 5AM Ventures, Montreux Equity Partners, TPG Biotech

Description:

EPIRUS is focusing on the central development of a broad pipeline of biosimilar monoclonal antibodies and therapeutic proteins, optimized for use within the SCALE™ disposable manufacturing system, and designed to be deployed in an "In Market, For Market" ™ manufacturing configuration.